Monoclonal antibody injections safe and effective for COVID-19 treatment, Pittsburgh researchers find

Injections of monoclonal antibodies to treat COVID-19 appears to be just as effective as IV infusions, according to a clinical trial from the University of Pittsburgh School of Medicine and UPMC. The antibody cocktail is most effective when used in patients within five days of developing COVID-19 symptoms, but IV administration has led to delays in care due to staffing shortages during surge periods.

Leave a Reply